Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
Alexander E DrilonVivek SubbiahOliver GautschiPascale TomasiniFilippo de BraudBenjamin J SolomonDaniel Shao-Weng TanGuzmán AlonsoJuergen WolfKeunchil ParkKoichi GotoVictoria SoldatenkovaSylwia SzymczakScott S BarkerTarun PuriAimee Bence LinHerbert Ho-Fung LoongBenjamin BessePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
fusion-positive NSCLC.